Advanced Proteome Therapeutics Corporation
APCH.V
TSX
| 04/30/2023 | 01/31/2023 | 10/31/2022 | 07/31/2022 | 04/30/2022 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 52.60K | 110.90K | 77.90K | -428.70K | 65.60K |
| Depreciation & Amortization | 100.00 | 100.00 | 100.00 | -3.20K | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 138.10K | 278.20K | 253.60K | 255.60K | 227.20K |
| Operating Income | -138.10K | -278.20K | -253.60K | -255.60K | -227.20K |
| Income Before Tax | -1.50M | -332.80K | -258.50K | -117.20K | -509.20K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.50M | -332.80K | -258.50K | -117.20K | -509.20K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 24.10K | 54.80K | 48.80K | 41.00K | 41.30K |
| Net Income | -1.48M | -278.00K | -209.70K | -76.20K | -467.80K |
| EBIT | -138.10K | -278.20K | -253.60K | -255.60K | -227.20K |
| EBITDA | -138.00K | -276.90K | -252.40K | -254.50K | -226.00K |
| EPS Basic | -0.04 | -0.01 | -0.01 | 0.00 | -0.01 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| EPS Diluted | -0.04 | -0.01 | -0.01 | 0.00 | -0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| Average Basic Shares Outstanding | 40.71M | 40.31M | 39.68M | 39.68M | 39.68M |
| Average Diluted Shares Outstanding | 40.71M | 40.31M | 39.68M | 39.68M | 39.68M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
